Protector Forsikring ASA (PROT.OL)
Oslo, NO
Protector Forsikring ASA functions as a general insurer, offering a broad spectrum of insurance solutions to commercial clients, public sector entities, and specialized affinity markets. The company's operations span Norway, Denmark, Sweden, the United Kingdom, and Finland, and are structured into Commercial Lines of Business and Public Lines of Business segments. Its product portfolio encompasses coverage for individuals, vehicles, real estate, legal liabilities, and changes of ownership. Distribution for its non-marine offerings is exclusively conducted through insurance brokers. Founded in 2003, the company maintains its principal office in Oslo, Norway.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.17% | -1.97% | -2.10% | -11.81% | -5.13% | -12.32% | +12.51% | +170.30% | +407.56% | +481.91% | +2,945.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Specialty: +11.0%+26.1% ★ Q2'26: +3.8% (vs Q2'25)
-
EPS growth Insurance - Specialty: +18.3%+69.5% ★ Q2'26: +3.4% (vs Q2'25)
-
FCF margin FCF growth · Insurance - Specialty: +39.7%+17.6% ★ Q2'26: +16.3% (vs Q2'25)
-
EBIT margin Insurance - Specialty: +18.3%+24.1% ★ Q2'26: +25.0% (vs Q2'25)
-
ROIC Insurance - Specialty: +10.3%+30.1% ★ Q2'26: +34.4% (vs Q2'25)
-
Share dilution Insurance - Specialty: +0.5%+1.5% Q2'26: +0.0% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Specialty: 0.25×0.66× Q2'26: 0.59× (vs Q2'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 4 EPS Ana. |
Dec 2028 3 Rev. Ana. 4 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.63B
est: 2.86B (-8.1%)
|
3.38B
est: 3.40B (-0.8%)
|
2.96B
est: 4.16B (-28.8%)
|
3.08B
est: 4.76B (-35.3%)
|
4.36B
est: 4.72B (-7.7%)
|
5.52B
est: 5.11B (+8.0%)
|
5.93B
est: 5.95B (-0.4%)
|
5.99B
est: 6.91B (-13.3%)
|
9.72B
est: 9.65B (+0.7%)
|
11.69B
est: 12.33B (-5.2%)
|
14.74B
est: 14.06B (+4.9%)
|
15.94B
15.83B – 16.05B
+13.4% YoY
|
17.53B
17.35B – 17.69B
+10.0% YoY
|
19.38B
18.99B – 19.76B
+10.5% YoY
|
| EBITDA |
548.05M
est: 641.55M (-14.6%)
|
556.47M
est: 762.65M (-27.0%)
|
477.18M
est: 932.70M (-48.8%)
|
16.46M
est: 1.07B (-98.5%)
|
-22.71M
est: 1.06B (-102.1%)
|
1.07B
est: 1.14B (-6.3%)
|
1.45B
est: 1.33B (+8.4%)
|
1.77B
est: 1.55B (+14.1%)
|
1.99B
est: 2.16B (-7.8%)
|
2.13B
est: 2.88B (-26.2%)
|
3.56B
est: 3.28B (+8.4%)
|
3.72B
3.70B – 3.75B
+13.4% YoY
|
4.09B
4.05B – 4.13B
+10.0% YoY
|
4.52B
4.43B – 4.61B
+10.5% YoY
|
| EBIT |
536.14M
est: 623.15M (-14.0%)
|
541.09M
est: 740.77M (-27.0%)
|
459.94M
est: 905.94M (-49.2%)
|
-5.21M
est: 1.04B (-100.5%)
|
-52.06M
est: 1.03B (-105.1%)
|
1.04B
est: 1.11B (-6.0%)
|
1.42B
est: 1.30B (+9.4%)
|
1.71B
est: 1.50B (+13.7%)
|
1.93B
est: 2.10B (-8.0%)
|
2.05B
est: 2.81B (-27.0%)
|
3.56B
est: 3.21B (+11.0%)
|
3.63B
3.61B – 3.66B
+13.4% YoY
|
4.00B
3.96B – 4.03B
+10.0% YoY
|
4.42B
4.33B – 4.51B
+10.5% YoY
|
| Net Income |
464.24M
est: 385.20M (+20.5%)
|
452.68M
est: 434.60M (+4.2%)
|
476.72M
est: 432.80M (+10.1%)
|
-295.40M
est: -166.26M (-77.7%)
|
-4.53M
est: 31.53M (-114.4%)
|
979.20M
est: 997.17M (-1.8%)
|
1.23B
est: 1.21B (+2.1%)
|
1.38B
est: 556.68M (+147.7%)
|
1.51B
est: 1.21B (+24.3%)
|
1.54B
est: 1.52B (+1.3%)
|
2.65B
est: 2.69B (-1.7%)
|
2.05B
2.02B – 2.15B
-23.8% YoY
|
2.33B
2.14B – 2.52B
+13.6% YoY
|
2.48B
2.21B – 2.75B
+6.5% YoY
|
| SGA |
51.30M
est: 46.51M (+10.3%)
|
162.00M
est: 55.28M (+193.0%)
|
178.07M
est: 67.61M (+163.4%)
|
233.27M
est: 77.25M (+202.0%)
|
269.22M
est: 76.66M (+251.2%)
|
370.92M
est: 82.98M (+347.0%)
|
41.22M
est: 96.65M (-57.3%)
|
42.19M
est: 112.27M (-62.4%)
|
—
est: 156.80M (-100.0%)
|
—
est: 34.52M (-100.0%)
|
—
est: 39.34M (-100.0%)
|
44.61M
44.30M – 44.92M
+13.4% YoY
|
49.06M
48.56M – 49.51M
+10.0% YoY
|
54.23M
53.14M – 55.31M
+10.5% YoY
|
| EPS |
5.48
est: 4.68 (+17.0%)
|
5.25
est: 5.28 (-0.6%)
|
5.53
est: 5.26 (+5.1%)
|
-3.52
est: -2.02 (-74.1%)
|
-0.06
est: 0.38 (-114.5%)
|
11.96
est: 12.12 (-1.4%)
|
14.96
est: 14.67 (+1.9%)
|
16.70
est: 6.77 (+146.7%)
|
18.30
est: 14.76 (+24.0%)
|
18.70
est: 18.21 (+2.7%)
|
31.70
est: 32.27 (-1.8%)
|
25.02
24.17 – 25.70
-22.5% YoY
|
28.71
25.66 – 30.14
+14.8% YoY
|
30.64
26.47 – 32.98
+6.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-26 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-19 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-06 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-05 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-04 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-29 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-15 | B+ | 3/5 | 4/5 | 5/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hans Didring | Deputy Chief Executive Officer | 16M | male |
| Henrik Wold-Golfetto Hoye | Chief Executive Officer | 15M | male |
| Dag Marius Nereng | Chief Investment Officer | 13M | male |
| Amund Gronvold Skoglund | Chief Financial Officer | 9M | male |
| Ditlev de Vibe Vanay | Chief Financial Officer | 9M | male |
| Stuart Winter | Country Manager UK | 8M | male |
| Leonard Bijl | IT Director | 7M | — |
| Fredrik Landelius | MD of Nordics & Country Manager Sweden | 6M | male |
| Cathrine Wessel Poulsen | Deputy Employees Representative Member & Country Manager of Norway | 5M | female |
| Stefan Salonen | Head of Underwriting & General Agent | — | male |
| Bjarte Jensen | Chief Underwriter of Public Sector - UK | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PROT.OL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
